Stock Market News
Blog
Market News & Insights.
A curated feed of headlines from trusted financial sources, refreshed automatically.
All
American Banker
Atas
Bonds Analysis & Opinion
Commodities & Futures News
Commodities Analysis & Opinion
Company News
Cryptocurrency News
Cryptocurrency Opinion & Analysis
Earnings Call Transcripts
Earnings Reports and Whispers
Economic Indicators News
Economy News
ETF Analysis & Opinion
Forex News
Forex News
Forex Opinion & Analysis
Insider Trading News
Investing Analysis
Market Overview
Most Popular Analysis
Press Releases
SEC Filings
Stock Analyst Ratings
Stock Market Investment Ideas
Stock Market News
Stock Markets Analysis & Opinion
SWOT Analysis News
Top Stories - MarketWatch
Yahoo Finance
Dow Jones
ZeroHedge
Calculated Risk
Top Stories - MarketWatch
It’s a rough housing market. Goldman Sachs expects it to get worse.
As bad as it is for the housing market — starts and transactions flat for the last three years with mortgage rates over 7% — it can still get worse.
Stock Analyst Ratings
Baird cuts Werner Enterprises stock rating on macro headwinds
Stock Market News
Why is Genuit stock plunging today?
Earnings Call Transcripts
Earnings call transcript: Lime posts solid Q3 2026 growth as AI traction builds
Economic Indicators News
Poland’s industrial output rises 4.6% in September
Economic Indicators News
Polish corporate wages rise 5.9% in September, miss forecasts
Stock Analyst Ratings
Baird downgrades Heartland Express stock rating on macro concerns
Stock Market News
Virgin Media O2 owners to challenge UK regulator on Netomnia deal
Bonds Analysis & Opinion
10-Year T-Note at Key Resistance After Hot Inflation Data: Webinar Replay
Earnings Reports and Whispers
Barco stock tumbles on weak outlook and soft Q3 results
Stock Analyst Ratings
Morgan Stanley initiates Genmab stock coverage with Equalweight rating
Stock Analyst Ratings
Stifel upgrades Trex stock rating on demand momentum, raises PT to $55
Stock Analyst Ratings
Morgan Stanley initiates Bicara Therapeutics stock with overweight rating
Stock Analyst Ratings
Morgan Stanley initiates Immix Biopharma stock with overweight rating
Earnings Call Transcripts
Earnings call transcript: Gentian Diagnostics posts record Q3 2026 sales
Earnings Reports and Whispers
ABB ADR earnings missed by $0.10, revenue fell short of estimates
Commodities Analysis & Opinion
Oil Futures Hold Higher Amid Prevailing Stances From Middle East
Company News
BW LPG subsidiary to sell vessel for low US$80 million
Stock Market News
Why is Comet stock rallying today?
Company News
OVHcloud FY26 slides: first positive FCF, growth accelerates
Earnings Reports and Whispers
Genuit sinks 16% as warm weather hits heating, annual profit seen below consensus
Company News
Embla Medical Q3 2026 slides: margins hold at 22% despite growth slowdown
Economy News
Netflix to report; OpenAI’s reported fundraising plans - what’s moving markets
Stock Market News
Why is ABB stock sliding today?
Stock Market News
Capita shares fall 3.4% after capital markets event postponement
Stock Analyst Ratings
Morgan Stanley initiates Zenas Biopharma stock coverage with Equalweight rating
Stock Analyst Ratings
Morgan Stanley initiates Lakefront Biotherapeutics stock with Equalweight rating
Stock Analyst Ratings
Evommune stock initiated at Overweight by Morgan Stanley on dermatitis drug potential
Stock Analyst Ratings
Morgan Stanley initiates Incyte stock coverage with Equalweight rating
Headlines and summaries above are provided by their respective publishers via public RSS feeds. Trading & Finance does not claim authorship of this content.